February 13, 2021
Beginning March 15, healthcare providers may use their clinical judgement to vaccinate individuals age 16-64 who are deemed to be at the very highest risk for morbidity and mortality from COVID-19 as a direct result of one or more of the severe health conditions included in this provider bulletin.
Vaccine Prioritization (as vaccine supply allows)
1) Currently vaccines may be distributed to populations identified in Phase 1A and Phase 1B, Tier 1.
2) Beginning March 15, healthcare providers may use their clinical judgement to vaccinate individuals age 16-64 who are deemed to be at the very highest risk for morbidity and mortality from COVID-19 as a direct result of one or more of the following severe health conditions:
Cancer, current with debilitated or immunocompromised state
Chronic kidney disease, stage 4 or above
Chronic pulmonary disease, oxygen dependent
Down syndrome
Immunocompromised state (weakened immune system) from solid organ transplant
Pregnancy
Sickle cell disease
Heart conditions, such as heart failure, coronary artery disease, or cardiomyopathies (excludes hypertension)
Severe obesity (Body Mass Index ≥ 40 kg/m2)
Type 2 diabetes mellitus with hemoglobin A1c level greater than 7.5%
OR
If as a result of a developmental or other severe high-risk disability one or more of the following applies:
The individual is likely to develop severe life-threatening illness or death from COVID-19 infection
Acquiring COVID-19 will limit the individual’s ability to receive ongoing care or services vital to their well-being and survival
Providing adequate and timely COVID care will be particularly challenging as a result of the individual’s disability
The list of eligible conditions is subject to change as additional scientific evidence is published and as CDPH obtains and analyzes additional state-specific data.
